Actinium Pharmaceuticals, Inc. — Director's Dealing 2018

Jul 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2018-07-13

Reporting Person: Steinhart Richard I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-13	Options to purchase common stock	$0.7829	A	75000	Acquired	2028-07-13	Common Stock (75000)	Direct

Footnotes

F1: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.